Risk of second non-breast primary cancer in Chinese breast cancer patients with germline BRCA1/2 pathogenic variants. Liu J, Chu F, Yao L, Sun J, et al. Breast Cancer Res Treat 2026;215:50.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu J, Chu F, Yao L, Sun J, et al. Risk of second non-breast primary cancer in Chinese breast cancer patients with germline BRCA1/2 pathogenic variants. Breast Cancer Res Treat 2026;215:50.
PMID: 41493635